Serum Institute of India seeks permission from DCGI to manufacture 'Sputnik V' COVID-19 vaccine in the country

Advertisement
Serum Institute of India seeks permission from DCGI to manufacture 'Sputnik V' COVID-19 vaccine in the country
Business Insider
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. The Pune-based firm has also sought approval for test analysis and examination.

Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.

"The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India," a source said.

Advertisement

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

The vaccine was given emergency use authorisation (EUA) by the DCGI in April.

A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.

Advertisement

SEE ALSO:
The Indian government is doling out ₹1500 crore to reserve 300 million of Biological-E’s COVID-19 vaccine doses
Huawei announces first devices with HarmonyOS — set to take on Apple and Google with its in-house operating system
OnePlus Nord CE 5G full specifications leaked days ahead of launch – heavily inspired by the original Nord
Five fintech ideas that are raking in the most amount of money
{{}}